Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off points.
Pain and spinal cord imaging measures in children with demyelinating disease.
Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
[Treatment of transplantation of NT-3 gene modified olfactory ensheathing cells on experimental autoimmune encephalomyelitis in rats].
Effects of magnetization transfer on T1 contrast in human brain white matter.
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
The Use of Fourth-generation Optical Coherence Tomography in Multiple Sclerosis: A Review.
Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells.
Progression in multiple sclerosis is associated with low endogenous NCAM.
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Determination of nitrite and nitrate in cerebrospinal fluid by microchip electrophoresis with microsolid phase extraction pre-treatment.
[Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria and therapy].
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Correction: Acute Disseminated Encephalomyelitis Onset: Evaluation Based on Vaccine Adverse Events Reporting Systems.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.
Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
Mechanisms of pain in multiple sclerosis: A combined clinical and neurophysiological study.
Pregnancy and multiple sclerosis.

Pages